ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ORMP Oramed Pharmaceuticals Inc

2.35
0.005 (0.21%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Oramed Pharmaceuticals Inc ORMP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.005 0.21% 2.35 08:00:01
Open Price Low Price High Price Close Price Previous Close
2.38 2.35 2.45 2.35 2.345
more quote information »

Recent News

Date Time Source Heading
20/3/202400:00GLOBEScilex Holding Company Announces Repayment in Full of the..
07/3/202409:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202400:42EDGAR2Form 8-K - Current report
21/2/202400:30PRNUSOramed Letter to Shareholders
31/1/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202408:45EDGAR2Form 8-K - Current report
20/1/202408:45EDGAR2Form 8-K - Current report
09/1/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202405:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/12/202301:26EDGAR2Form 8-K - Current report
19/12/202308:45EDGAR2Form 8-K - Current report
10/11/202309:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/9/202306:34EDGAR2Form 8-K - Current report
23/9/202301:38PRNUSSorrento Therapeutics, Inc. Announces the Consummation of..
22/9/202308:11PRNUSOramed Announces $101,875,000 Short-Term Senior Secured Note..
22/9/202306:05GLOBEScilex Holding Company Announces the Consummation of the..
13/9/202323:00GLOBEScilex Holding Company Enters into Non-Binding Term Sheets..
13/9/202322:47EDGAR2Form 8-K - Current report
11/8/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:30EDGAR2Form 8-K - Current report
07/8/202323:20EDGAR2Form 8-K - Current report
02/8/202321:45PRNUSOramed Signs Term Sheet with HTIT to Create a Joint Venture..
14/7/202307:00EDGAR2Form 8-K - Current report
20/6/202321:55PRNUSOramed to Present at the 83rd American Diabetes Association..
18/5/202321:55PRNUSOramed to Present at Novel Therapies for Type 2 Diabetes &..
15/5/202323:05PRNUSOramed Announces that its Chinese Partner, HTIT, has..

Your Recent History

Delayed Upgrade Clock